Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 06, 2021

SELL
$233.58 - $259.14 $1.7 Million - $1.88 Million
-7,264 Closed
0 $0
Q1 2021

Apr 07, 2021

BUY
$221.91 - $258.6 $50,151 - $58,443
226 Added 3.21%
7,264 $1.81 Million
Q4 2020

Feb 22, 2021

BUY
$216.38 - $257.67 $1.52 Million - $1.81 Million
7,038 New
7,038 $1.63 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wc Walker & Associates, Inc. Portfolio

Follow Wc Walker & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wc Walker & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wc Walker & Associates, Inc. with notifications on news.